0000-0003-2441-6089 About
Professor,
Department of Biomedical Science,
Acharya Narendra Dev College, University of Delhi, India
My group focuses on bacteriophages and the encoded lytic enzymes as alternatives/adjuncts to antibiotics. We have purified over 200 mycobacteriophages and several mycobacteriophage-derived endolysins as potential therapeutic candidates against Tuberculosis and Non-tuberculous Mycobacterial (NTM) infections. We also work on discovering small-molecule inhibitors as drug candidates that target Mur enzymes in M. tuberculosis.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (31)
- Mycobacteriophages: Therapeutic Approach for Mycobacterial Infections. Save
- Insights into the genomic features and lifestyle of B1 subcluster mycobacteriophages. Save
- Genome announcement and analysis of five new mycobacteriophages belonging to the F, G, K, and P clusters Save
- Bacteriophages: The natural combatants to fight AMR Save
- Unlocking prophage potential: In silico and experimental analysis of a novel Mycobacterium fortuitum LysinB containing a peptidoglycan-binding domain Save
- Discovery and Characterization of a Novel LysinB from F2 Sub-Cluster Mycobacteriophage RitSun Save
- Beyond antibiotics: Phage-encoded lysins against Gram-negative pathogens. Save
- Phage-encoded lysins as promising antibacterials against uropathogenic Escherichia coli. Save
- ). Identification of Perturbed Pathways Rendering Susceptibility to Tuberculosis in Type 2 Diabetes Mellitus Patients Using BioNSi Simulation of Integrated Network of Implicated Human Genes Save
- Alternative Treatment of Secondary Bacterial and Fungal Infections Associated with Covid-19 Save